E Infante, SJ Heasman… - Journal of Leukocyte …, 2011 - Soc Leukocyte Biology ... User Name Password Sign In. Statins inhibit T-acutelymphoblasticleukemia cell adhesion and migration through Rap1b. ... Abstract/FREE Full Text. 13.↵: Real PJ,; Ferrando AA. (2009) NOTCH inhibition and glucocorticoid therapy in T-cell acutelymphoblasticleukemia. ... Related articles - All 3 versions
D Bhojwani, D Pei, JT Sandlund, S Jeha… - Leukemia, 2011 - nature.com ... ETV6-RUNX1-positive childhood acutelymphoblasticleukemia: improved outcome with contemporary therapy. ... Top of page Abstract. ETV6-RUNX1 fusion is the most common genetic aberration in childhood acutelymphoblasticleukemia (ALL). ...
LM Heltemes-Harris, MJL Willette… - The Journal of …, 2011 - jem.rupress.org ... Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acutelymphoblastic leukemia. ... As STAT5 is critical for the differentiation, proliferation, and survival of progenitor B cells, this transcription factor may play a role in acutelymphoblasticleukemia (ALL). ... Related articles - All 3 versions
[HTML] from hematologylibrary.orgRM Demarest, N Dahmane… - Blood, 2011 - bloodjournal.hematologylibrary.org ... LYMPHOID NEOPLASIA. Notch is oncogenic dominant in T-cell acutelymphoblastic leukemia. ... T-cell acutelymphoblasticleukemia (T-ALL) is a hematologic neoplasm characterized by malignant expansion of immature T cells. ... Cited by 5 - Related articles - All 4 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
